Area of research
Pulmonary and Respiratory Medicine · Gastroenterology
Research interest
Research interests include Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes, Sarcoma Diagnosis and Treatment, and Colorectal Cancer Treatments and Studies.
How Should Primary Pulmonary Sarcoma be Staged? Results of an International Multicentre Analysis
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study
<sup>18</sup>F-Fluorodeoxyglucose Uptake in <i>PDGFRA</i>-Mutant Gastrointestinal Stromal Tumors
Outcome of Patients with Curative-Intent Treatment for Primary Pulmonary Sarcoma: Results of an International Multicenter Database
How should Primary Pulmonary Sarcoma be staged? Results of an International Multicenter Database
<i>KIT/PDGFRA</i> Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study.
Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
Role of adjuvant imatinib dose in radically resected GIST harboring KIT exon 9 mutations.
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor).
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
FAP-related desmoid tumours treated with low dose chemotherapy: Results from a multicentre retrospective analysis.
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
Rechallenge in advanced GIST progressing to imatinib, sunitinib and regorafenib: An Italian survey.
Rechallenge in GIST progressing to imatinib, sunitinib and regorafenib: An Italian survey